Live Price
Live Volume
Biogen Market Segments
Overnight
*No Trades in Segment
After Hours
| Open | $232.65 |
|---|---|
| Close | $232.65 |
| Low | $232.65 |
| Low Change | 0.00 (0.00%) |
| High | $232.65 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 311.373K |
| Dollar Volume | $72.44M |
Regular Trading Hours
| Open | $235.75 |
|---|---|
| Close | $232.65 |
| Low | $232.36 |
| Low Change | -3.39 (-1.44%) |
| High | $236.87 |
| High Change | +1.12 (+0.48%) |
| Range | $4.51 |
| Volume | 1.132M |
| Dollar Volume | $263.27M |
Premarket
| Open | $235.87 |
|---|---|
| Close | $235.87 |
| Low | $235.87 |
| Low Change | 0.00 (0.00%) |
| High | $235.87 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 382 |
| Dollar Volume | $90.10K |
After Hours Yesterday
| Open | $235.35 |
|---|---|
| Close | $235.35 |
| Low | $235.35 |
| Low Change | 0.00 (0.00%) |
| High | $235.35 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 258.241K |
| Dollar Volume | $60.78M |
Regular Trading Hours Yesterday
| Open | $236.46 |
|---|---|
| Close | $235.36 |
| Low | $235.22 |
| Low Change | -1.25 (-0.53%) |
| High | $240.99 |
| High Change | +4.53 (+1.92%) |
| Range | $5.78 |
| Volume | 1.19M |
| Dollar Volume | $279.98M |
Premarket Yesterday
| Open | $236.01 |
|---|---|
| Close | $235.62 |
| Low | $234.97 |
| Low Change | -1.04 (-0.44%) |
| High | $236.74 |
| High Change | +0.73 (+0.31%) |
| Range | $1.77 |
| Volume | 1.483K |
| Dollar Volume | $349.42K |
Biogen News
4 days agoinvesting.comBiogen options flow points to short iron condor ahead of Oct. 16 expiry
5 days agoinvesting.comJPMorgan gets bullish on Biogen ahead of 2027 catalysts
5 days agobarrons.comBiogen Stock Could Keep Gaining. A J.P. Morgan Upgrade Is Just the Beginning.
5 days agoinvesting.comWhy is Biogen stock climbing today?
2 months agoinvesting.comWolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
3 months agoinvesting.comBiogen beats quarterly estimates as newer drugs fuel growth
3 months agoinvesting.comBiogen tumbles 8.7% as breakthrough Alzheimer’s data is clouded by dosing paradox
3 months agoinvesting.comBiogen stock rises on positive Alzheimer’s drug trial data
3 months agobarrons.comBiogen’s Alzheimer’s Drug Leaves Questions Unanswered, and That’s a Problem
3 months agoinvesting.comWhy is Biogen stock rallying today?
Biogen Top Trades
Biogen's top trade so far today returned +0.48%, while the top short trade returned -1.78%.
Biogen Moving Averages
| 5 Day Moving Average (SMA5) | $230.49 |
|---|---|
| 10 Day Moving Average (SMA10) | $225.93 |
| 20 Day Moving Average (SMA20) | $225.30 |
| 50 Day Moving Average (SMA50) | $219.21 |
| 100 Day Moving Average (SMA100) | $210.34 |
| 200 Day Moving Average (SMA200) | $197.55 |
Biogen Statistics
| Average Volume (30 Days) | 1.02M |
|---|---|
| P/E Ratio (Current) | 39.95 |
| EPS (Current) | $5.65 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $2.70B |
| Cash Ratio | 0.33 |
| Current Ratio | 1.87 |
| Quick Ratio | 1.26 |
| Debt to Equity | 0.43 |
| Enterprise Value | $40.15B |
| EV to EBITDA | 17.45 |
| EV to Sales | 4.00 |
| Price to Book | 1.77 |
| Price to Cash Flow | 11.58 |
| Price to Free Cash Flow | 12.37 |
| Price to Sales | 3.33 |
| Return on Assets | 0.03% |
| Return on Equity | 0.04% |
Biogen Stock Splits
There have been no stock splits for Biogen (BIIB).
Biogen Dividends
There have been no dividends for Biogen (BIIB).